Prediction models in obstetrics: understanding the treatment paradox and potential solutions to the threat it poses

BJOG: An International Journal of Obstetrics and Gynaecology

Volumn 123, Issue 7, 2016, Pages 1060-1064

  Cheong See, F ^a,b   Allotey, J ^a,b   Marlin, N ^a   Mol, B W ^c   Schuit, E ^d,e   ter Riet, G ^f   Riley, R D ^g   Moons, K G M ^d   Khan, K S ^a,b   Thangaratinam, S ^a,b  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^c UNIVERSITY OF ADELAIDE   (Australia)

^d UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^e STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f UNIVERSITY OF AMSTERDAM   (Netherlands)

^g KEELE UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

FEMALE; FETUS OUTCOME; HUMAN; MALE; MATERNAL OUTCOME; NOTE; OBSTETRICS; OUTCOME ASSESSMENT; PARAMETERS CONCERNING THE FETUS, NEWBORN AND PREGNANCY; PATIENT CARE; PREDICTION; PREECLAMPSIA; PRIORITY JOURNAL; PROCESS DEVELOPMENT; STANDARDIZATION; TREATMENT INDICATION; VALIDATION PROCESS;

EID: 84978374486     PISSN: 14700328     EISSN: 14710528     Source Type: Journal    
DOI: 10.1111/1471-0528.13859     Document Type: Note

References (13)

1. Steyerberg EW, Moons KG, van der Windt DA, Hayden JA, Perel P, Schroter S, et al. Prognosis Research Strategy (PROGRESS) 3: prognostic model research. PLoS Med 2013;10:e1001381.
2. Grove WM, Zald DH, Lebow BS, Snitz BE, Nelson C. Clinical versus mechanical prediction: a meta-analysis. Psychol Assess 2000;12:19–30.
3. Kleinrouweler CE, Cheong-See FM, Collins GS, Kwee A, Thangaratinam S, Khan KS, et al. Prognostic models in obstetrics: available, but far from applicable. Am J Obstet Gynecol 2015. pii: S0002-9378(15)00596-7.
4. Steyerberg EW. Clinical Prediction Models. New York: Springer-Verlag, 2009. XXVIII, pp. 500.
5. NICE. Hypertension in Pregnancy. The Management of Hypertensive Disorders During Pregnancy. NICE Clinical Guideline 107. London: National Institute for Health and Care Excellence, 2011.
6. Duley L, Gulmezoglu AM, Henderson-Smart DJ. Magnesium sulphate and other anticonvulsants for women with pre-eclampsia. Cochrane Database Syst Rev 2003;(2):CD000025.
7. Rao SC, Chhatriwalla AK, Kennedy KF, Decker CJ, Gialde E, Spertus JA, et al. Pre-procedural estimate of individualized bleeding risk impacts physicians’ utilization of bivalirudin during percutaneous coronary intervention. J Am Coll Cardiol 2013;61:1847–52.
8. Schuit E, Groenwold RH, Harrell FE Jr, de Kort WL, Kwee A, Mol BW, et al. Unexpected predictor-outcome associations in clinical prediction research: causes and solutions. CMAJ 2013;185:E499–505.
9. von Dadelszen P, Payne B, Li J, Ansermino JM, Broughton-Pipkin F, Cote AM, et al. PIERS Study Group. Prediction of adverse maternal outcomes in pre-eclampsia: development and validation of the fullPIERS model. Lancet 2011;377:219–27.
10. NIHR. HTA – 09/22/163: Development and validation of a Prediction model for Risk of complications in Early onset Pre eclampsia (PREP) ISRCTN 40384046. [www.hta.ac.uk/project/2401.asp]. Accessed 17 June 2015.
11. Peduzzi P, Concato J, Feinstein AR, Holford TR. Importance of events per independent variable in proportional hazards regression analysis II. Accuracy and precision of regression estimates. J Clin Epidemiol 1995;48:1503–10.
12. Cukjati D, Robnik-Sikonja M, Rebersek S, Kononenko I, Miklavcic D. Prognostic factors in the prediction of chronic wound healing by electrical stimulation. Med Biol Eng Compu 2001;39:542–50.
13. Bertens LC, Reitsma JB, Moons KG, van Mourik Y, Lammers JW, Broekhuizen BD, et al. Development and validation of a model to predict the risk of exacerbations in chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis 2013;8:493–9.